Neal Koller, CEO and Chairman of Alphyn Biologics, talks with Laura Hill, CONNECTpreneur Anchor and Phoenix Fund General Partner in Tysons Corner, Virginia in February, 2020
Alphyn is a life science company developing proprietary drug therapy for treating serious skin diseases. The initial target indication are skin infections caused by deadly drug-resistant MRSA bacteria based on our proprietary Multi-Target Therapeutic (MTT) plant-derived technology platform. The company’s website is www.alphynbiologics.com.
Neal Koller has been President & CEO and a Director for six life science businesses guiding them to milestone achievement or exit. He began his career at Wyeth Pharmaceuticals where he achieved notable successes in both large division and early stage business responsibilities. Neal has over 30 years as a top executive with a successful history of building, running and growing entrepreneurial and complex global companies.
Founded in 2012 and based in Washington, DC, CONNECTpreneur is a one of the largest global communities of over 20,000 founders, entrepreneurs, private investors, angels, VCs, CXOs and business leaders who celebrate innovation and entrepreneurship. We organize the country’s leading monthly virtual and live forums featuring meaningful networking, deal making, gamechanging speakers, and showcases of disruptive early stage companies. Visit us at connectpreneur.org.